{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T15:24:03Z","timestamp":1790522643376,"version":"4.1.0"},"reference-count":57,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2013,7,25]],"date-time":"2013-07-25T00:00:00Z","timestamp":1374710400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0068841","type":"journal-article","created":{"date-parts":[[2013,7,25]],"date-time":"2013-07-25T22:30:01Z","timestamp":1374791401000},"page":"e68841","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":11,"title":["Orthosteric Binding of \u03c1-Da1a, a Natural Peptide of Snake Venom Interacting Selectively with the \u03b11A-Adrenoceptor"],"prefix":"10.1371","volume":"8","author":[{"given":"Arhamatoulaye","family":"Ma\u00efga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Merlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elodie","family":"Marcon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Rouget","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maud","family":"Larregola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Gilquin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Fruchart-Gaillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyne","family":"Lajeunesse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Marchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Lorphelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Bellanger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger J.","family":"Summers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana S.","family":"Hutchinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bronwyn A.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Servent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Gilles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,7,25]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1586\/epr.09.45","article-title":"Venomics as a drug discovery platform","volume":"6","author":"P Escoubas","year":"2009","journal-title":"Expert Rev Proteomics"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1039\/b819311h","article-title":"Conotoxins: natural product drug leads","volume":"26","author":"R Halai","year":"2009","journal-title":"Nat Prod Rep"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/nrd1197","article-title":"Therapeutic potential of venom peptides","volume":"2","author":"RJ Lewis","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S1359-6446(99)01454-3","article-title":"Conopeptides: From deadly venoms to novel therapeutics","volume":"5","author":"GS Shen","year":"2000","journal-title":"Drug Discov Today"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.toxicon.2011.03.009","article-title":"G protein-coupled receptors, an unexploited animal toxin targets: Exploration of green mamba venom for novel drug candidates active against adrenoceptors","volume":"59","author":"A Ma\u00efga","year":"2012","journal-title":"Toxicon"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1111\/j.1471-4159.2009.06092.x","article-title":"Muscarinic toxins: tools for the study of the pharmacological and functional properties of muscarinic receptors","volume":"109","author":"D Servent","year":"2009","journal-title":"J Neurochem"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"34451","DOI":"10.1074\/jbc.M305410200","article-title":"Allosteric alpha 1-adrenoreceptor antagonism by the conopeptide rho-TIA","volume":"278","author":"IA Sharpe","year":"2003","journal-title":"J Biol Chem"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1096\/fj.07-8658com","article-title":"Beta-cardiotoxin: a new three-finger toxin from Ophiophagus hannah (king cobra) venom with beta-blocker activity","volume":"21","author":"N Rajagopalan","year":"2007","journal-title":"Faseb J"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1476-5381.2009.00532.x","article-title":"Isolation and pharmacological characterization of AdTx1, a natural peptide displaying specific insurmountable antagonism of the alpha(1A)-adrenoceptor","volume":"159","author":"L Quinton","year":"2010","journal-title":"Br J Pharmacol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1111\/j.1476-5381.2010.00966.x","article-title":"Identification of a novel snake peptide toxin displaying high affinity and antagonist behaviour for the alpha2-adrenoceptors","volume":"161","author":"C Rouget","year":"2010","journal-title":"Br J Pharmacol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1124\/mol.105.020883","article-title":"Identification of various allosteric interaction sites on M1 muscarinic receptor using 125I-Met35-oxidized muscarinic toxin 7","volume":"69","author":"C Fruchart-Gaillard","year":"2006","journal-title":"Mol Pharmacol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1124\/mol.108.050773","article-title":"Different interactions between MT7 toxin and the human muscarinic M1 receptor in its free and N-methylscopolamine-occupied states","volume":"74","author":"C Fruchart-Gaillard","year":"2008","journal-title":"Mol Pharmacol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"31661","DOI":"10.1074\/jbc.M111.261404","article-title":"Structural Model of Ligand-G Protein-coupled Receptor (GPCR) Complex Based on Experimental Double Mutant Cycle Data: MT7 SNAKE TOXIN BOUND TO DIMERIC hM1 MUSCARINIC RECEPTOR","volume":"286","author":"C Marquer","year":"2011","journal-title":"Journal of Biological Chemistry"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1124\/mol.63.1.26","article-title":"Chemical synthesis of MT1 and MT7 muscarinic toxins: critical role of Arg-34 in their interaction with M1 muscarinic receptor","volume":"63","author":"G Mourier","year":"2003","journal-title":"Mol Pharmacol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0014-2999(96)00136-7","article-title":"Binding of the labelled muscarinic toxin 125I-MT1 to rat brain muscarinic M1 receptors","volume":"305","author":"M Waelbroeck","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejphar.2004.01.029","article-title":"Action of the muscarinic toxin MT7 on agonist-bound muscarinic M1 receptors","volume":"487","author":"MC Olianas","year":"2004","journal-title":"European Journal of Pharmacology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"50923","DOI":"10.1074\/jbc.M406424200","article-title":"Muscarinic Toxin 7 Selectivity Is Dictated by Extracellular Receptor Loops","volume":"279","author":"A Kukkonen","year":"2004","journal-title":"Journal of Biological Chemistry"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1074\/jbc.M112.430785","article-title":"Conopeptide rho-TIA Defines a New Allosteric Site on the Extracellular Surface of the alpha1B-Adrenoceptor","volume":"288","author":"L Ragnarsson","year":"2013","journal-title":"J Biol Chem"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ejphar.2004.12.011","article-title":"Differential antagonism by conotoxin rho-TIA of contractions mediated by distinct alpha1-adrenoceptor subtypes in rat vas deferens, spleen and aorta","volume":"508","author":"V Lima","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1124\/mol.110.067454","article-title":"Quantification of functional selectivity at the human alpha(1A)-adrenoceptor","volume":"79","author":"BA Evans","year":"2011","journal-title":"Mol Pharmacol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Y Cheng","year":"1973","journal-title":"Biochem Pharmacol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0014-2999(99)00550-6","article-title":"The assessment of antagonist potency under conditions of transient response kinetics","volume":"382","author":"A Christopoulos","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0165-6147(00)89066-5","article-title":"Analysis of competitive agonist-antagonist interactions by nonlinear regression","volume":"16","author":"MJ Lew","year":"1995","journal-title":"Trends Pharmacol Sci"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1749-6632.1997.tb48166.x","article-title":"An improved method for analysis of competitive agonist\/antagonist interactions by non-linear regression","volume":"812","author":"MJ Lew","year":"1997","journal-title":"Ann N Y Acad Sci"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1006\/jmbi.1993.1626","article-title":"Comparative protein modelling by satisfaction of spatial restraints","volume":"234","author":"A Sali","year":"1993","journal-title":"J Mol Biol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1093\/nar\/gkg103","article-title":"GPCRDB information system for G protein-coupled receptors","volume":"31","author":"F Horn","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"D309","DOI":"10.1093\/nar\/gkq1009","article-title":"GPCRDB: information system for G protein-coupled receptors","volume":"39","author":"B Vroling","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1126\/science.1150577","article-title":"High-Resolution Crystal Structure of an Engineered Human {beta}2-Adrenergic G Protein Coupled Receptor","volume":"318","author":"V Cherezov","year":"2007","journal-title":"Science"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.toxicon.2008.05.020","article-title":"A rational nomenclature for naming peptide toxins from spiders and other venomous animals","volume":"52","author":"GF King","year":"2008","journal-title":"Toxicon"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1124\/jpet.103.059840","article-title":"Application of a Kinetic Model to the Apparently Complex Behavior of Negative and Positive Allosteric Modulators of Muscarinic Acetylcholine Receptors","volume":"308","author":"V Avlani","year":"2003","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"ref31","first-page":"229","article-title":"Structure\/activity relationships of M2 muscarinic allosteric modulators","volume":"9","author":"K Mohr","year":"2003","journal-title":"Receptors Channels"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1124\/mol.57.3.436","article-title":"Allosteric interactions between the antagonist prazosin and amiloride analogs at the human alpha(1A)-adrenergic receptor","volume":"57","author":"RA Leppik","year":"2000","journal-title":"Mol Pharmacol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"14312","DOI":"10.1021\/bi961024e","article-title":"Phenylalanine in the second membrane-spanning domain of alpha 1A-adrenergic receptor determines subtype selectivity of dihydropyridine antagonists","volume":"35","author":"N Hamaguchi","year":"1996","journal-title":"Biochemistry"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0014-5793(96)01286-0","article-title":"Amino acids of the alpha1B-adrenergic receptor involved in agonist binding: differences in docking catecholamines to receptor subtypes","volume":"399","author":"A Cavalli","year":"1996","journal-title":"FEBS Lett"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1248\/bpb.30.1891","article-title":"Asp125 and Thr130 in transmembrane domain 3 are major sites of alpha1b-adrenergic receptor antagonist binding","volume":"30","author":"K Takahashi","year":"2007","journal-title":"Biol Pharm Bull"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1248\/bpb.31.598","article-title":"Mutational analysis of the alpha 1a-adrenergic receptor binding pocket of antagonists by radioligand binding assay","volume":"31","author":"M Ahmed","year":"2008","journal-title":"Biol Pharm Bull"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"11698","DOI":"10.1074\/jbc.275.16.11698","article-title":"Novel aromatic residues in transmembrane domains IV and V involved in agonist binding at alpha(1a)-adrenergic receptors","volume":"275","author":"DJ Waugh","year":"2000","journal-title":"J Biol Chem"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"6322","DOI":"10.1074\/jbc.271.11.6322","article-title":"The unique nature of the serine interactions for alpha 1-adrenergic receptor agonist binding and activation","volume":"271","author":"J Hwa","year":"1996","journal-title":"J Biol Chem"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"16320","DOI":"10.1074\/jbc.274.23.16320","article-title":"Phe310 in transmembrane VI of the alpha1B-adrenergic receptor is a key switch residue involved in activation and catecholamine ring aromatic bonding","volume":"274","author":"S Chen","year":"1999","journal-title":"J Biol Chem"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"23189","DOI":"10.1074\/jbc.270.39.23189","article-title":"Identification of critical determinants of alpha 1-adrenergic receptor subtype selective agonist binding","volume":"270","author":"J Hwa","year":"1995","journal-title":"J Biol Chem"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"25366","DOI":"10.1074\/jbc.M103152200","article-title":"Phe-308 and Phe-312 in transmembrane domain 7 are major sites of alpha 1-adrenergic receptor antagonist binding. Imidazoline agonists bind like antagonists","volume":"276","author":"DJ Waugh","year":"2001","journal-title":"J Biol Chem"},{"key":"ref42","first-page":"165","article-title":"Modeling and mutagenesis of the human alpha 1a-adrenoceptor: orientation and function of transmembrane helix V sidechains","volume":"4","author":"JM Wetzel","year":"1996","journal-title":"Receptors Channels"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"33422","DOI":"10.1074\/jbc.M111.261651","article-title":"Identification of essential cannabinoid-binding domains: structural insights into early dynamic events in receptor activation","volume":"286","author":"JY Shim","year":"2011","journal-title":"J Biol Chem"},{"key":"ref44","article-title":"Effects of rho-Da1a a peptidic alpha1a-adrenoceptor antagonist in human isolated prostatic adenoma and anesthetized rats","author":"S Palea","year":"2012","journal-title":"Br J Pharmacol in press"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S1046-5928(03)00140-2","article-title":"Expression of EGFP-amino-tagged human mu opioid receptor in Drosophila Schneider 2 cells: a potential expression system for large-scale production of G-protein coupled receptors","volume":"31","author":"BG Perret","year":"2003","journal-title":"Protein Expression and Purification"},{"key":"ref46","first-page":"37","article-title":"Production of the Human D2S Receptor in the Methylotrophic Yeast P. pastoris?","volume":"10","author":"S Grunewald","year":"2004","journal-title":"Receptors and Channels"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/nrd1875","article-title":"New concepts in drug discovery: collateral efficacy and permissive antagonism","volume":"4","author":"T Kenakin","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1124\/pr.108.000992","article-title":"Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery","volume":"62","author":"T Kenakin","year":"2010","journal-title":"Pharmacol Rev"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1111\/j.1476-5381.2012.01896.x","article-title":"Agonist-dependent modulation of arterial endothelinA receptor function","volume":"166","author":"MG Compeer","year":"2012","journal-title":"Br J Pharmacol"},{"key":"ref50","first-page":"362","article-title":"Detection, quantitation, and verification of allosteric interactions of agents with labeled and unlabeled ligands at G protein-coupled receptors: interactions of strychnine and acetylcholine at muscarinic receptors","volume":"48","author":"S Lazareno","year":"1995","journal-title":"Mol Pharmacol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"4384","DOI":"10.1073\/pnas.84.13.4384","article-title":"Identification of residues required for ligand binding to the beta-adrenergic receptor","volume":"84","author":"CD Strader","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"28318","DOI":"10.1074\/jbc.271.45.28318","article-title":"Activation of the alpha1b-adrenergic receptor is initiated by disruption of an interhelical salt bridge constraint","volume":"271","author":"JE Porter","year":"1996","journal-title":"J Biol Chem"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1126\/science.289.5480.739","article-title":"Crystal structure of rhodopsin: A G protein-coupled receptor","volume":"289","author":"K Palczewski","year":"2000","journal-title":"Science"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1126\/science.1215904","article-title":"Crystal structure of a lipid G protein-coupled receptor","volume":"335","author":"MA Hanson","year":"2012","journal-title":"Science"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1126\/science.1194396","article-title":"Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists","volume":"330","author":"B Wu","year":"2010","journal-title":"Science"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"25677","DOI":"10.1074\/jbc.M702311200","article-title":"Critical role for the second extracellular loop in the binding of both orthosteric and allosteric G protein-coupled receptor ligands","volume":"282","author":"VA Avlani","year":"2007","journal-title":"J Biol Chem"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.toxicon.2010.05.001","article-title":"The three-finger toxin MT\u03b1 is a selective \u03b12B-adrenoceptor antagonist","volume":"56","author":"K Koivula","year":"2010","journal-title":"Toxicon"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0068841","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,19]],"date-time":"2019-07-19T16:17:30Z","timestamp":1563553050000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0068841"}},"subtitle":[],"editor":[{"given":"Vladimir N.","family":"Uversky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,7,25]]},"references-count":57,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2013,7,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0068841","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,25]]}}}